These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10839487)

  • 1. Efficacy and safety of cefdinir in the treatment of maxillary sinusitis.
    Steurer M; Schenk P
    Eur Arch Otorhinolaryngol; 2000; 257(3):140-8. PubMed ID: 10839487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora.
    Cohen R; Navel M; Grunberg J; Boucherat M; Geslin P; Derriennic M; Pichon F; Goehrs JM
    Pediatr Infect Dis J; 1999 May; 18(5):403-9. PubMed ID: 10353511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.
    Gwaltney JM; Savolainen S; Rivas P; Schenk P; Scheld WM; Sydnor A; Keyserling C; Leigh A; Tack KJ
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1517-20. PubMed ID: 9210677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of symptomatic chronic adenotonsillar hypertrophy with amoxicillin/clavulanate potassium: short- and long-term results.
    Sclafani AP; Ginsburg J; Shah MK; Dolitsky JN
    Pediatrics; 1998 Apr; 101(4 Pt 1):675-81. PubMed ID: 9521955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis.
    Sher LD; McAdoo MA; Bettis RB; Turner MA; Li NF; Pierce PF
    Clin Ther; 2002 Feb; 24(2):269-81. PubMed ID: 11911557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential.
    Bulow C; Langdon A; Hink T; Wallace M; Reske KA; Patel S; Sun X; Seiler S; Jones S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30463925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.
    Block SL; Schmier JK; Notario GF; Akinlade BK; Busman TA; Mackinnon GE; Halpern MT; Nilius AM
    Curr Med Res Opin; 2006 Sep; 22(9):1839-47. PubMed ID: 16968587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media.
    Block SL; Busman TA; Paris MM; Bukofzer S
    Pediatr Infect Dis J; 2004 Sep; 23(9):834-8. PubMed ID: 15361722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience.
    Rakkar S; Roberts K; Towe BF; Flores SM; Heyd A; Warner J
    Int J Clin Pract; 2001 Jun; 55(5):309-15. PubMed ID: 11452678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis.
    Camacho AE; Cobo R; Otte J; Spector SL; Lerner CJ; Garrison NA; Miniti A; Mydlow PK; Giguere GC; Collins JJ
    Am J Med; 1992 Sep; 93(3):271-6. PubMed ID: 1524078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients.
    Powers JL; Gooch WM; Oddo LP
    Pediatr Infect Dis J; 2000 Dec; 19(12 Suppl):S174-80. PubMed ID: 11144401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
    Henry DC; Kapral D; Busman TA; Paris MM
    Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twice-daily dosing of loracarbef 200 mg versus 400 mg in the treatment of patients with acute maxillary sinusitis.
    Zeckel ML; Johns D; Masica DN; Farlow D
    Clin Ther; 1995; 17(2):214-30. PubMed ID: 7614522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of cefdinir in acute bacterial rhinosinusitis.
    Hadley JA
    Expert Opin Pharmacother; 2006 Jun; 7(8):1075-83. PubMed ID: 16722817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis.
    Sydnor TA; Scheld WM; Gwaltney J; Nielsen RW; Huck W; Therasse DG
    Ear Nose Throat J; 1992 May; 71(5):225-32. PubMed ID: 1505371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia.
    Bansal A; Singhi SC; Jayashree M
    Indian J Pediatr; 2006 Apr; 73(4):305-9. PubMed ID: 16816491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J; Profant M; Kostrica R; Waskin H
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of amoxicillin and clavulanate every 12 hours vs every 8 hours for treatment of acute bacterial maxillary sinusitis.
    Seggev JS; Enrique RR; Brandon ML; Larsen LS; Van Tuyl RA; Rowinski CA
    Arch Otolaryngol Head Neck Surg; 1998 Aug; 124(8):921-5. PubMed ID: 9708721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years.
    Holas C; Chiu YL; Notario G; Kapral D
    Clin Ther; 2005 Dec; 27(12):1950-60. PubMed ID: 16507381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.